We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

92 hedge funds and large institutions have $144M invested in Adverum Biotechnologies in 2015 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 25 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 25

4% less funds holding

Funds holding: 96 → 92 (-4)

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

44% less capital invested

Capital invested by funds: $255M → $144M (-$111M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

55% less call options, than puts

Call options by funds: $2.8M | Put options by funds: $6.17M

Holders
92
Holders Change
-4
Holders Change %
-4.17%
% of All Funds
2.57%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
18
Increased
37
Reduced
25
Closed
22
Calls
$2.8M
Puts
$6.17M
Net Calls
-$3.37M
Net Calls Change
-$15.4M

Top Buyers

Rank Fund Capital Flow
1
Axa
Axa
France
+$6.52M
2
NI
Numeric Investors
Massachusetts
+$6.21M
3
CCM
Cadian Capital Management
New York
+$6.05M
4
SM
Sabby Management
Florida
+$4.81M
5
AC
Ascend Capital
California
+$4.59M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$11.6M
2
JP Morgan Chase
JP Morgan Chase
New York
-$7.12M
3
FCM
Frontier Capital Management
Massachusetts
-$6.64M
4
Invesco
Invesco
Georgia
-$6.35M
5
LCM
Laurion Capital Management
New York
-$4.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$1.25M -$884K -6,920 -31%
DCM
27
DAFNA Capital Management
California
$1.16M +$1.8M +14,060 New
CC
28
CQS Cayman
Cayman Islands
$1.14M +$1.77M +13,841 New
Group One Trading
29
Group One Trading
Illinois
$1.11M -$117K -913 -6%
TI
30
Turner Investments
Pennsylvania
$915K +$1.42M +11,109 New
TCIM
31
TIAA CREF Investment Management
New York
$905K +$375K +2,936 +36%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$723K +$128K +1,004 +13%
PG
33
PEAK6 Group
Illinois
$717K +$1.11M +8,707 New
JP Morgan Chase
34
JP Morgan Chase
New York
$711K -$7.12M -55,708 -87%
Millennium Management
35
Millennium Management
New York
$659K -$11.6M -90,488 -92%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$645K -$472K -3,692 -32%
Geode Capital Management
37
Geode Capital Management
Massachusetts
$604K +$62.6K +490 +7%
BIM
38
BlackRock Investment Management
Delaware
$558K -$20.2K -158 -2%
PAM
39
Panagora Asset Management
Massachusetts
$530K +$777K +6,081 +1,737%
FAM
40
Fred Alger Management
New York
$527K +$569K +4,450 +229%
LCM
41
Laurion Capital Management
New York
$497K -$4.03M -31,524 -84%
BCM
42
Bridgeway Capital Management
Texas
$479K +$742K +5,810 New
JG
43
Jefferies Group
New York
$412K +$319K +2,500 +100%
TC
44
TFS Capital
Pennsylvania
$294K +$455K +3,563 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$293K -$1.28K -10 -0.3%
SCA
46
Secor Capital Advisors
New York
$282K +$438K +3,425 New
TI
47
Trexquant Investment
Connecticut
$281K +$437K +3,420 New
TA
48
Teachers Advisors
New York
$266K +$49.6K +388 +14%
Charles Schwab
49
Charles Schwab
California
$233K – – –
AllianceBernstein
50
AllianceBernstein
Tennessee
$205K -$894 -7 -0.3%
1
2
3 4 5

ADVM Hedge Fund Activity: Q3 2015 in Review

92 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q3 2015, worth a combined $144M — down 44% from $255M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ADVM and 18 opened new positions — a net loss of 4 holders — while 25 trimmed existing stakes and 37 added.

The largest buyer was Axa, adding an estimated $6.52M. The largest seller was Millennium Management, cutting an estimated $11.6M.

  • 92 institutional investors held Adverum Biotechnologies (ADVM) as of Q3 2015, down from 96 in Q2 2015.
  • Funds reported $144M of Adverum Biotechnologies stock for Q3 2015, down 44% quarter-over-quarter.
  • 18 funds opened new Adverum Biotechnologies positions in Q3 2015 and 22 closed out, a net change of -4 holders.
  • The largest Adverum Biotechnologies buyer in Q3 2015 was Axa, an estimated $6.52M added.
  • The largest Adverum Biotechnologies seller in Q3 2015 was Millennium Management, an estimated $11.6M sold.

Based on aggregated 13F filings for Q3 2015.